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ABSTRACT 
 
 
Mesenchymal stem cells (MSCs) are multipotent stromal cells that have the 
potential to differentiate into various cells lineages, including adipocytes, chondrocytes, 
osteocytes, and fibroblasts.  Due to their ability to regenerate damaged tissues, MSCs 
have the potential to be the future of new cell-based therapies.  However, identification of 
MSCs has not been standardized, resulting in various approaches among researchers to 
isolate this rare cell population.  The purpose of this project was to identify parameters 
for isolating MSCs from murine bone marrow.  This was accomplished by combining a 
staining protocol that utilizes the unique surface characteristics of MSCs with the 
negative selection for CD45 and Ter-119, and then the negative selection for CD44 in the 
remaining cell population.   
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BACKGROUND 
 
 
The Gerstein Lab  
 
 This project was completed in the lab of Dr. Rachel Gerstein of the 
Microbiological and Physiological Systems Department within the University of 
Massachusetts Medical School.  Dr. Gerstein’s lab is primarily concerned with B cell and 
T cell development, particularly that of investigating the process of V(D)J recombination.  
This process involves the rearrangement of chromosomal DNA required for 
immunoglobulin and T-cell receptor genes (Murphy et al., 2012).  Her research has 
indicated the bone marrow microenvironment includes factors derived from bone marrow 
stromal cells that are essential to the development of B cell precursors (reviewed in 
Labrie et al., 2004).  In addition, she has found that defects in the microenvironment 
underlie the reduced B-cell development with age.   
 Dr. Gerstein has hypothesized a diminishing population of mesenchymal stem 
cells (MSCs) is involved in the reduced B-cell development in old mice due to the 
potential for MSC to generate bone marrow stromal cells.  B-cell development in adults 
occurs in the bone marrow and is strictly dependent on close interaction of B-cell 
progenitors and stromal cells that produce cytokines capable of supporting B-cell survival 
and proliferation (Corcione, 2006).  Studies have also concluded that under some, but not 
all, MSC conditions promote B-lymphocyte survival (Tabera et al., 2008).  To facilitate 
the investigation into the relationship between B-cell development, B-cell supporting 
stromal cells and MSCs, it is important to effectively identify and isolate stem cells from 
the bone marrow.    
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Stem Cells 
A stem cell is a long-lived cell that can divide and either give rise to a new copy 
of itself or to other specialized cell types (Mummery, 2011).   These cells are capable of 
differentiating into various cells depending on the stem cell’s origin.   There are several 
types of stem cells, each having key properties that dictate how it will develop.  Toti-
potent stem cells form all cell types of the embryo and adult, and the extra-embryonic 
tissue such as the placenta.   Germ cells and newly fertilized zygotes through about the 4-
cell stage are considered to be toti-potent.   If the stem cell is able to form cell types of 
the embryo and adult except for the extra-embryonic structures, these cells are known as 
pluripotent.   Embryonic stem (ES) cells are exclusively pluripotent, and thus offer a wide 
range of differentiation capabilities.   All other stem cells found within the specialized 
tissue of the fetus and adult are considered to be multi-potent.   These cells have the 
ability to form many cells in the body, but not all of them.   The remaining stem cell type 
is uni-potent.   These cells are the most restricted, and are only able to differentiate into 
one other cell type (Mummery, 2011).    
Stem cells generally divide in two different ways (Figure 1).   Symmetric cell 
division involves the stem cell dividing into two identical new stem cells.   This allows 
the stem cell to divide in a way that each daughter cell maintains the stem cell properties.   
The other way in which stem cells can divide is asymmetric cell division.   In this 
division, the stem cell divides so that one daughter cell remains a stem cell and the other 
differentiates to a specialized cell, no longer having stem cell properties (Mummery, 
2011).   Asymmetric cell division ensures a pool of stem cells remains unchanged as well 
as available for differentiation. 
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Figure 1: Diagram of Symmetric (left) and Asymmetric (right) 
Stem Cell Division.   Blue indicates specialized or differentiated cells, 
and yellow indicates stem cells.   (Mummery, 2007) 
 
 
 
Studies have been performed to assess the potential of embryonic and adult stem 
cells for cell based therapies (Xiao, 2012).   Human embryonic stem (ES) cells have 
ethical and political concerns because isolating them from the inner cell mass destroys an 
embryo (blastocyst).   In addition to the social issues of these cells, it is also believed that 
ES cells pose the risk of immune rejection and complications with immunosuppressive 
therapies.   For these reasons, attention has been drawn to the use of adult stem cells.    
Adult stem cells are found within adult tissues.   Autologously harvested adult 
stem cells do not pose the same concerns as ES cells since immune rejection is not likely 
and they have not attracted the questions of ethical implications.   A limitation to the use 
of adult stem cells is that they are exceedingly rare in most tissues; however bone marrow 
has been identified as the most accessible source of adult stem cells (Mummery, 2011).    
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Bone Marrow-Derived Stem Cells 
Bone marrow contains two populations of multipotent adult stem cells, each from 
a distinct cell lineage and with distinct differentiation potentials.   These two populations 
are referred to as hematopoietic stem cells (HSC) and mesenchymal stem cells (MSC).   
Hematopoietic, or blood stem cells, are responsible for constantly repopulating the 
various types of blood cells (Xiao, 2012).   Blood cells do not have a long life within the 
body, thus the hematopoietic stem cells must constantly replenish the supply.   MSCs are 
able to form fat, bone, cartilage, muscle, and marrow stroma when differentiated.   In 
contrast to HSCs, most of the MSCs do not continue to divide once the growth of the 
skeleton has ceased.   However, it has been found that MSC when cultured in vitro are 
capable of not only dividing but also differentiating when in the presence of the correct 
growth factors (Xiao, 2012).    
Both marrow cell types are harvested from the bones of the patient or research 
subject by aspirating the bone marrow using a thick needle.   With gentle mechanical 
disruption, the hematopoietic and mesenchymal cells can be dissociated (Mummery, 
2011).   The cells can then be plated on tissue culture plastic and observed.   MSC rapidly 
adhere to the plastic, while the hematopoietic stem cells do not attach.   This has become 
a useful technique for separating the two cell types.    
 
Mesenchymal Stem Cells 
Alexander Friedenstein and coworkers in a series studies in the 1960s and 1970s, 
first demonstrated the osteogenic potential was associated with a unique subset of bone 
marrow cells (Bianco et al., 2008).   This potential cell subset was revealed by 
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heterotopic transplantation of BM cells.   Friedenstein distinguished these cells from the 
large majority of hematopoietic cells that were present by observing their rapid adherence 
to tissue culture plates.   In addition, the cells exhibited an appearance comparable to 
ﬁbroblasts, suggesting their origin was from the stromal compartment of BM.   
Friedenstein also showed BM cell suspensions, when in clonal density (density of cells 
that allow the formation of single-cell clones), are capable of giving rise to colonies 
initiated by single cells.   Colonies initiated from single cells (CFU-Fs, colony forming 
fibroblastic cells) were transplanted in vivo and demonstrated that skeletal tissues, 
including bone, cartilage, and fat, can be generated from a single BM stromal cell.   
Friedenstein referred to this single cell as an osteogenic stem cell or a BM stromal stem 
cell.   The name ‘mesenchymal stem cell’ was later proposed by Arnold Caplan, and is 
now the universal term for these multi-potent stromal cells (Bianco et al., 2008).    
MSC are considered important for regenerative medicine due to their ability to 
migrate to and repair injured tissues (Tabera et al., 2008).  They have also been 
considered for the treatment of autoimmune diseases and graft-versus-host disease.   
Initial experiments with MSCs in animal models have produced encouraging results; 
MSC have been shown to improve rheumatoid arthritis and multiple sclerosis in mouse 
models.   However, their use in the clinic must be approached with caution; there is 
evidence that MSC may also contribute to the maintenance of cancer stem cells due to 
their broad differentiation capabilities (Dazzi et al., 2007).   Another concern that must be 
addressed relates to the in vivo characterization and identification of MSC as there is a 
lack of a universal biomarker.   Without such marker, deciphering the reprogramming 
 10 
pathways and the molecular components that control the unique characteristics of MSCs 
has proven difficult (Dominci et al., 2006).    
 The defining characteristics of MSC are inconsistent among different 
laboratories.   The methods that have been implemented by individual laboratories to 
isolate and expand MSC have noticeable differences, and the tissue source varies.   
Because the tissue sources and isolation methodologies vary, it is difficult to determine 
whether the isolated and expanded cells are similar enough to compare experimental 
outcomes and develop universal MSC properties.   To begin to address these issues, a 
recent report from the International Society for Cellular Therapy (ISCT) stated that 
“multipotent mesenchymal stromal cells’ is the currently recommended designation for 
the plastic-adherent cells isolated from BM and other tissues that have often been labeled 
MSC” (Dominci et al., 2006).   In order to help alleviate these discrepancies, the 
Mesenchymal and Tissue Stem Cell Committee of the ISCT has proposed a “set of 
standards to define human MSC for both laboratory-based scientific investigations and 
for pre-clinical studies” (Dominici et al., 2006).   The three criteria set forth to define 
MSC (Table 1) are adherence to plastic, specific surface antigen (Ag) expression, and 
multipotent differentiation potential.    
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The first requirement is that the MSC must be plastic-adherent when maintained 
in standard culture conditions.   Secondly, at least 95% of the MSC population must 
express CD105 (endoglin), CD73 (ecto 5’ nucleotidase), and CD90 (Thy-1), when 
measured by flow cytometry.  CD271 has also been identified to be expressed on the 
surface by MSCs (Das et al., 2013).  These cells must also score less than 2% (of cells) 
positive for markers present on other types of marrow cells, such as CD45, CD34, CD14 
CD11b, CD79a or CD19 (also discussed in Figure 2).   Analysis of surface Ag expression 
allows for both accurate identification of a cell population and assessment of its relative 
heterogeneity.   This method is used extensively in immunology and hematology.   The 
final criteria used to identify MSCs is that when they are placed in in vitro differentiating 
conditions, the cells must be able to differentiate to osteoblasts, adipocytes, and 
chondroblasts (Dominici et al., 2006).   
It is important to show that populations of MSC do not contain extraneous cells, 
such as hematopoietic cells.   MSC do not express hematopoietic Ag, thus the lack of 
expression of these Ag are another way to validate the presence of MSC (Xiao, 2012).   A 
panel of antibodies specific for relevant Ags is used to exclude the cells most likely to be 
Table 1:  International Society for Cellular Therapy Definition 
of MSC Characteristics.   (Dominci et al., 2006) 
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found in MSC from bone marrow.   CD45 is a pan-leukocyte marker; CD34 marks 
primitive hematopoietic progenitors and endothelial cells; CD14 and CD11b are 
expressed on monocytes and macrophages.   The most likely hematopoietic cells to be 
found in an MSC cultures are CD79a and CD19, markers of B cells that may also adhere 
to MSC in culture (Dominici et al., 2006).   Figure 2 illustrates the markers thought to be 
applicable to MSC.    
 
Figure 2:  Diagram of Mesenchymal Stem Cell & Their Differentiation Markers. 
Figure taken from R&D Systems 
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The biologic property that most uniquely identifies MSC is their capacity for tri-
lineage mesenchymal differentiation.   Cells must be shown to differentiate into 
osteoblasts, adipocytes, and chondroblasts.   Differentiation to osteoblasts can be 
demonstrated by staining with Alizarin Red or von Kossa staining.   Adipocyte 
differentiation is most efficiently demonstrated by staining with Oil Red O, while 
chondroblast differentiation is demonstrated by staining with Alcian blue (Dominici et 
al., 2006).    
 
Lack of Validated Panels for Mouse MSC 
 The lack of well validated panels for mouse MSCs is a concern the research 
community has been interested in addressing.  Previous studies reported that CD44 
expression is a strong indicator of MSCs in both human and mouse bone marrow (Sun et 
al., 2003).  However, a recent study led by Mikael Sigvardsson, has released data that 
provides functional and molecular evidence suggesting primary mesenchymal cells reside 
in the CD44-negative cell fraction of the bone marrow (Sigvardsson et al., 2012).  
Because this finding is in opposition to the previous studies, Sigvardsson argues the in 
vitro culture of MSCs leads to the population of CD44-negative MSCs to undergo a 
conversion to the CD44 positive phenotype.  Although MSCs are a small population of 
the CD44-negative cells, and knowing that CD44 is also widely expressed in 
hematopoietic cells, Sigvardsson has suggested using the CD44 marker in combination 
with other negative markers such as CD45, can significantly facilitate the prospective 
isolation of MSCs from the bone marrow (Sigvardsson et al., 2012) 
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Antibodies Used in This Project 
CD45 PE-Cyanine7 is an anti-mouse antibody also known as leukocyte common 
antigen.  CD45 is expressed on all hematopoietic cells, excluding mature erythrocytes 
and platelets (Affymetrix EBioscience, 2013).   Because this particular antigen is unique 
to hematopoietic cells, it can utilized to negatively select for MSCs.   The PE-Cyanine7 
portion of the antibody enables the hematopoietic bone marrow cells to be fluorescently 
tagged for analysis and removal in flow cytometry.   Figure 3 demonstrates the staining 
of staining of bone marrow from B6 mice withPE-Cy7-CD45 (red line) to unstained cells 
(blue line).   A significant shift to the right is observed, indicating a large population of 
CD45-positive hematopoietic cells in the murine bone marrow.    
 
 
 
 
 
 
 
 
 
 
Another anti-mouse antibody that allows for negative selection of hematopoietic 
cells is Ter-119 FITC.   This antibody reacts with mouse erythroid cells ranging from 
early proerythroblasts to mature erythrocytes (Affymetrix EBioscience, 2013).   Red 
Figure 3: Results of staining of bone marrow from B6 mice 
withPE-Cy7-CD45 (red line) to unstained cells (blue line). 
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blood cells (RBCs) are differentiated from of hematopoietic stem cells, and contain 
hemoglobin to carry oxygen throughout the body.   Since CD45 is not expressed on 
erythroid cells, the combination of antibody to CD45 and TER-119 permits exclusion of 
the majority of hematopoietic cells when examining mesenchymal cells.  The FITC 
(fluorescein isothiocyanate) portion of the antibody enables the hematopoietic RBCs to 
be fluorescently tagged for analysis in flow cytometry.   Figure 4 demonstrates the 
staining bone marrow from B6 mice with FITC-TER119 antibody (red line) to the signal 
from unstained BM (blue line).  A significant shift to the right is observed, indicating a 
high number of RBCs in the murine bone marrow. 
 
 
 
 
 
 
 
 
 
 
CD44 antigen is expressed on both hematopoietic and non-hematopoietic cells, 
and functions as an adhesion molecule (Affymetrix EBioscience, 2013).  We used anti-
CD44 coupled to APC- the APC portion of this antibody acts to fluorescently tag the 
bone marrow cells for analysis in flow cytometry.   Our strategy was to first negatively 
Figure 4: Results of staining bone marrow from B6 mice with FITC-
TER-119 antibody (red line) to the signal from unstained BM (blue line). 
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selected BM cells using CD45 and Ter-119 to remove potential hematopoietic cells, and 
then to isolate CD44+ and CD44- cells to evaluate properties of these two populations.   
The left panel of Figure 5 demonstrates the staining of B6 murine bone marrow with 
APC-CD44 (red line) to unstained cells (blue line).   A significant shift to the right is 
observed indicating a high number of myeloid cells and memory T cells in murine bone 
marrow.  The right panel of Figure 5 is a plot of the CD44 intensity versus forward 
scatter (FSC).   FSC is proportional to cell size, showing that 3 distinct populations are 
readily detected, and that CD44 expression is well correlated with cell size. 
 
 
Figure 5 Left Panel: Results of staining bone marrow from B6 mice with  
APC-CD44 (red line) to unstained cells (blue line).   
Right Panel: a plot of the CD44 intensity versus forward scatter (FSC). 
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PROJECT PURPOSE 
 
The purpose of this project was to determine parameters that are effective in 
identifying the rare population of mesenchymal stem cells (MSCs) within murine bone 
marrow.   This will be used in future studies to prospectively isolate pure populations of 
MSC, as well as to increase the accuracy of experiments aiming to analyze MSC from the 
bone marrow.  Two antibodies, Ter-119 and CD45, known to be present on marrow cells 
other than MSCs was used to remove those cells using FACS analysis.  Then an antibody 
against CD44 will be used to examine the remaining cells.  Recent reports show that, 
prior to previous studies, MSC are negative for CD44 (Sigvardsson et al., 2012).  This 
strategy was used to isolate BM using FACS sorting.    
Several different mouse lines were used.   C57bl/6 (B6) mice (non-stimulated) 
were compared to MxCre x Tomato mice (stimulated with Poly(I:C)).  MxCre was 
chosen due to the suggestion bone-marrow-derived MSCs may be a heterogeneous 
population with the Mx population (Park et al., 2012).  Poly(I:C) is an immunostimulant 
that is known to induce the production of cytokines.  B6 control mice will also be 
compared to Tomato x Twist mice (in which the Tomato gene is upregulated via 
the Twist promoter).  Twist has been found to be expressed in the early stages of skeletal 
development in osteochondral progenitor cells (Kang et al., 2004) and is known to 
promote mesenchymal cell morphology (Liu et al., 2010).   In addition, two MSC cell 
lines, 10T½ and OP9 (Lagergren et al., 2007), were subjected to RT-PCR to qualitatively 
test for the expression of genes specific to adipocytes, one lineage differentiated from of 
MSCs. 
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METHODS 
 
Bone Marrow Aspiration 
 
Bone marrow from B6, B1, MxCre x Twist, and Tomato x Twist mice was 
collected.   This was done by sacrificing a mouse of each strain, and removing the hind 
and front legs.   The skin and muscle was scrapped away from the long bones using a 
small razor blade.   The epiphysis of the bones were then cut with the razor, allowing 
aspiration needles to be inserted into the medullary cavity.    
Using prepared staining media, the bone marrow was aspirated into a tissue 
culture plate using a syringe and 27.5 gauge needle.   Upon the collection of the bone 
marrow, a syringe and 22 gauge needle was then used to disrupt the tissue with repeated 
flushing.   The cells were then transferred into 15 mL tubes and placed in a centrifuge to 
be spun at 1500 rpm for 5 minutes, resulting in a cell pellet.   The remaining supernatant 
was aspirated, leaving only the cell pellet in the tube.   The pellet was then resuspended 
in 1 mL of staining media, and a cell count was acquired with the use of the MACSQuant 
analyzer.    
 
FACS Staining 
 Staining for the FACS analysis was completed using the CD45 PE-Cyanine7, Ter-
119 FITC, and CD44 APC antibodies (discussed in the Background).   Cell suspensions 
of the bone marrow were prepared in 6 x 10
7 
cells/mL in staining media and filtered 
through 0.45 µm nylon mesh.   Aliquots of 100 ul of the mAB were placed in 1.5 ml 
eppendorf tubes and vortexed thoroughly and the PE, APC, FITC reagents were 
centrifuged at approximately 6000 x g in the eppendorf centrifuge for 5 minutes.   Then 
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the amount of each stain/mAB required was determined with the calculation 40 µl of 
diluted reagent per 40 µl of cells to be stained.   Each reagent was diluted into staining 
media according to the desired dilution ratio. 
 The diluted stains were then placed into the appropriate wells of a 96 well plate, 
in aliquots of 40 µl each.   Once the stains were in the wells, 40 µl of the appropriate cells 
were added to each well.   It is important that the stain be placed in the wells before the 
cells, so the cells can thoroughly engage the stain prior to attaching to plastic.  The 96 
well plate was then incubated for approximately 20 minutes on ice, then washed 2 and ½ 
times with staining media at 4° C.   The cells were finally resuspended for the FACS 
analysis in approximately 300 µl of staining media containing the nucleic acid stain 
propidium iodide (PI) with a final concentration of 1 µg/ml.    
 
FACS Analysis 
The stained bone marrow cells were then analyzed through fluorescence activated 
cell sorting (FACS).   FACs analysis provides a method for sorting a heterogeneous 
mixture of biological cells, one cell at a time.   This allows for the stained murine bone 
marrow cells to be separated into gates based on their surface marker expression.  When 
establishing a gate during FACS analysis, the subset of cells within that gate are 
preserved for additional analysis and the cells not within the gate are removed.  A 
depiction of the gating progression utilized to isolate the MSCs can be found in 
Appendix A. 
To begin, the cells were gated for live cells with the axes FSC-A (forward 
scattered area) by Live (Appendix A, graphs 1 and 2).  FSC-A arranged each cell by their 
 20 
size based on area and allowed for the exclusion of cells that may be in the process of 
dividing and thus, are larger in size.  The Live axis allowed for the exclusion of dead 
cells because they appear more fluorescent than live cells due to their increased 
permeability to the staining.  Once the live cell population had been established, a gate 
for singlets using the axes FSC-A by FSCH-H was imposed (Appendix A, graph 3).   
FSC-A arranged the cells by their size based on area while FSC-H (forward scattered 
height) arranged the cells by their size based on height.  This ensured that cells stuck 
together did not continue through the analysis.   The singlet cell population subset was 
then gated for CD45 negative and Ter-119 negative cells (Appendix A, graph 4 and 5).   
By negatively selecting for CD45 and Ter-119, any hematopoietic cells within the bone 
marrow were removed from the analysis.   After the negative gating, the remaining cell 
population was identified as either CD44 negative or CD44 positive by using the axes 
FSC-A by CD44-APC (Appendix A, graph 5).   Knowing that CD44 is a usually on 
hematopoietic cells, and MSC activity was found to be increased in the CD44-negative 
fraction (ref), CD44-negative cells were isolated as a “candidate” population of MSCs.    
 
Cell Culture of 10T½ and OP9 Cell Lines 
 Cell lines were initially maintained in 1.5 mL in cryostorage.   To culture the 
cells, one tube of each line was removed and thawed.   To expedite the thawing process, 
the 1.5 mL tubes were partially filled with 10% media containing 5 mL of fetal bovine 
serum and 45 mL of RPMI-1640 media.   The media used to thaw the cells was then 
transferred into a 15 mL tube and additional 10% media was added to reach a total of 10 
mL.   This process was completed for each of the five cell lines.   Once each cell line was 
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incorporated into 10% media, the 15 mL tubes were placed in a centrifuge and spun at 
1500 rpm for 5 minutes, resulting in a pellet.   The remaining supernatant was aspirated, 
leaving only the pellet in the tube.    
 A 20% media solution was developed for the growth of the cells.   This solution 
contained 10 mL of fetal bovine serum and 40 mL of RPMI-1640 media.   The pellets in 
each of the cell line’s 15 mL tubes were resuspended in 10 mL of the 20% media.   The 
10 mL solutions were then placed in individual tissue culture flasks and placed in an 
incubator at 37° C and 5% CO2.   The cell lines were grown for approximately 5 days.   
 
RT-PCR 
Reverse transcription polymerase chain reaction (RT-PCR) was performed to 
semi-quantitatively detect gene expression through the creation of cDNA transcripts from 
RNA.   These RNAs were acquired from MSC cell lines, referred to as 10T½  and OP9 
(Lagergren et al., 2007).   In addition to the stock cDNA of each cell line, dilutions of 
1:10 and 1:100 of the cDNA were also prepared.   Controls were also developed by 
including  samples that did not contain RT III during the cDNA preparation, and samples 
that did not contain cDNA (only master mix and dH20).    
The primers selected for this RT-PCR are known to be genes expressed by 
adipocytes, which are a differentiated form of MSCs.   The first primer aP2, adipocyte 
Protein 2, is a carrier protein for fatty acids (sense 5’-TGATGCCTTTGTGGGAACCT-
3’, antisense 3’-GCCTGCCACTTTCCTTGTG-5’).   The second primer c/EBPα, 
CCAAT-enhancer-binding proteins, is found in adipocytes and critical regulator of white 
adipose tissue formation (LeBlanc et al., 2012) (sense 5’-CCCACTCAGCTTAC-
 22 
AACAGG-3’, antisense 3’-GCTGGCGACATACAGTACAC-5’).   The final primer used 
was β-actin as the loading control (sense 5’-TTCTTTGCAGCTCCTTCGTTGCCG-3’, 
antisense 3’ TGGATGGCTACGTACATGGCTGGG-5’).   The PCR tubes were filled 
with 1 µl of the respective sample shown in Table 2, and 19 µl of the master mix shown 
in Table 3.   Three master mixes were developed in total – one for each set of primers.   
The RT-PCR was completed by using the MasterCycler program “STAT5”, previously 
established by the Gerstein lab (Table 4).    
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RESULTS 
 
 
The purpose of this project was to identify parameters that are effective in 
identifying the rare population of mesenchymal stem cells within murine bone marrow.   
Upon the identification of the MSCs, the cells were then isolated using FACS sorting 
using a combination of positive and negative criteria.   The mouse strains experimentally 
tested included a comparison of B6 to MxCre x Tomato (Park et al., 2012) and a 
comparison of B6 to Tomato x Twist (Kang et al., 2004).   In addition, two MSC cell 
lines, 10T½ and OP9, were subjected to RT-PCR to  semi-quantitatively test for the 
expression of genes specific to adipocytes, a differentiated form of these stem cells.   
 
B6 and MxCre x Twist FACS 
 
The B6 mouse was used as a control, while the MxCre x Tomato mice were 
injected with Poly(I:C) on four consecutive days.   Poly(I:C) is an immunostimulant that 
is known to interact with TLR3.   By injecting the mice with Poly(I:C), the production of 
cytokines induced, which in turn activates the Mx promoter, permitting expression of the 
CRE recombinase.   When CRE is expressed, the tomato reporter undergoes CRE-
mediated rearrangement and allows tomato expression, which is readily detected by 
FACS.   The bone marrow from one B6 mouse and two MxCre x Tomato mice were 
collected and prepared with the stated procedures.    
The bone marrow cells were first negatively selected using CD45 and Ter-119 to 
remove potential hematopoietic cells, and then CD45-TER-119- cells were negatively 
selected for CD44.  Figure 6 shows the percent of tomato-negative and tomato-positive 
populations found within the CD45-TER-119-CD44- compartment of the marrow of each 
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mouse strain.   The B6 mouse (left panel) was found to have a tomato-negative 
population of approximately 99.9% and a tomato-positive of approximately 0.08% (false 
positive rate).   The MxCre x Tomato marrow (right panel) was found to have a tomato-
negative population of approximately 25.2% and a tomato-positive population of 
approximately 73.6%.   Thus, the MxCre x Tom mice show a distinct population of 
candidate tomato+ MSCs.   
 
  
 
 
 
 
 
 
 
Figure 6:  CD44 FACS analysis of B6 murine bone marrow cells (left) 
and MxCre x Tomato murine bone marrow cells (right). 
 
 
 
B6 and Tomato x Twist FACS 
 
The B6 mouse was selected as a control and the Tomato x Twist as the 
experimental subjects.   The bone marrow from one B6 mouse and two Tomato x Twist 
mice were collected and prepared with the stated procedures.   Figure 7 shows the 
percent tomato-positive and tomato-negative populations found within CD45-TER-119-
CD44- BM cells from each mouse strain.   The B6 mouse (left panel) was found to have a 
tomato-negative population of approximately 95.8% and a tomato-positive population of 
B6 Control          MxCre x Tomato 
+ + 
- - 
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approximately 4.03% (false positive).   The Tomato x Twist mice (right panel) was found 
to have a tomato -negative population of approximately 46.2% and a tomato -positive 
population of approximately 53.6%.  The Tomato x Twist marrow tomato -positive and 
tomato -negative populations were sorted to compare properties of these candidate MSCs.   
 
 
 
 
 
 
 
 
 
 
Figure 7:  CD44 FACS analysis of B1 murine bone marrow cells (left) 
and Tom x Twist murine bone marrow cells (right). 
 
 
 
RT-PCR of 10T½ and OP9 Cell Lines 
 
To help identify genes that are associated with the differentiation of MSCs, the 
known MSCs lines 10T½ and OP9 were analyzed by RT-PCR using primers for aP2, 
c/EBPα, and the house-keeping gene β-actin.  aP2, c/EBPα are expressed at low levels in 
MSC lines and at higher levels when these lines develop into adipocytes (fat cells).  The 
first primer tested was aP2, adipocyte protein 2, the carrier protein for fatty acids.   It was 
expected that if the cell lines expressed this particular gene, a band would develop in the 
gel.   Figure 8 shows that both the 10T½ (lanes 1 to 3) and OP9 (lanes 6 to 8) cells 
B6 Control                Tomato x Twist 
- - 
+ + 
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expressed a significant level of aP2.   It was also noticed that the dilutions of cDNA for 
the 10T½ cells showed a progressively decreased expression.   Using cDNA from the 
OP9 cells, the dilutions did not exhibit the same decrease in expression, perhaps due to a 
stronger overall gene expression of aP2 within these cells.   In the control lanes 4, 5, 9, 
and 10, faint bands are observed.   Because they are smaller than the aP2 gene product 
bands, the bands in these lanes are attributed to primer dimers, therefore disregarded.    
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: RT-PCR data for cells 10T½ (lanes 1 to 3) and OP9 cells  
(lanes 6 to 8) cells using aP2 primers for adipocyte protein. 
 
 
The second primer tested was c/EBPα, the CCAAT-enhancer-binding protein that 
is found in adipocytes.   It was expected that if the cell lines expressed this particular 
protein, a band would develop in the gel.   Figure 9 shows that both the 10T½ cells 
(lanes 1 to 2) and OP9 cells (lanes 6 to 8) expressed a noticeable level of c/EBPα.   It was 
also found that the dilutions for the 10T½ cells showed a significantly decreased 
expression, indicating the successful diluting of the c/EBPα gene expression with the 
dilution of 1:100.   In regards to the OP9 cells, the dilutions showed a progressively 
decreased expression, indicating the successful diluting of the c/EBPα gene expression 
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with the dilution of 1:100.   In the control lanes 4, 5, 9, and 10, there are no noticeable 
bands observed.    
The final primer tested β-actin, as a control for the entire procedure, as β-actin is 
highly expressed in most cells.   This RT-PCR resulted in a strong signal in both the 
10T½ (lanes 11 to 13) and OP9 (lanes 16 to 18).   The control lanes 14, 15, 19, and 20 
exhibited very faint actin mRNA bands, which as seen in the aP2 gel, and might be 
attributed to low levels of DNA contamination of the cDNA.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: RT-PCR for cells 10T½ (lanes 1 to 2) and OP9 cells (lanes 6 to 8)  
using c/EBPα primers (lanes 1 to 10) and β-actin primers (lanes 11 to 20). 
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DISCUSSION 
 
 
This project tested the use of specific antibodies combined with reporter gene 
systems and FACS analysis in identifying and isolating the rare population of 
mesenchymal stem cells (MSCs).   Moreover, the negative selection for CD45 and Ter-
119 cells, followed by the negative selection for CD44 cells improves the ability to sort 
MSCs from the murine bone marrow.   This project also found that completing an RT-
PCR to test for the expression of adipocyte-specific genes is an appropriate means to 
further validate the presence of MSCs. 
 Beginning with the FACS analysis of the B6 and MxCre x Tomato mice, the 
results obtained indicate that treatment of the MxCre x Tomato mice with Poly(I:C) to 
induce conjunction with the strong MxCre promoter, significantly increases the tomato-
positive MSC population within the murine bone marrow.   The B6 control mouse 
exhibited less than 1% of tomato-positive cells, while the MxCre x Tomato mice 
exhibited approximately 74% of tomato-positive cells.   Because the bone marrow cells 
were first negatively selected using CD45 and Ter-119 to remove hematopoietic cells, 
and then negatively selected for CD44, it is expected this isolated cell population 
constitutes MSCs.   The additional enrichment of MSC provided by sorting tomato-
positive cells in this mouse model will be tested in future work in the Gerstein lab using 
qPCR. 
 The results from the FACS analysis of the B6 and Tomato x Twist mice indicate 
the up-regulation of the Tomato gene through the use of the Twist promoter can also 
increase the MSC population within the murine bone marrow.   The B6 control mouse 
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exhibited approximately 4% of tomato-positive cells, while the Tomato x Twist mice 
exhibited approximately 54% of tomato-positive cells.   The significant difference 
between these two population percentages suggests the Tomato gene expression be used 
to isolate MSCs.  The additional enrichment of MSC provided by sorting tomato-positive 
cells in this mouse model will be tested in future work in the Gerstein lab using qPCR. 
 Single cell sorts were completed with both FACS sorting experiments that are 
described.   Due to the limitation of time, RT-PCR analysis using these cells was not 
feasible.   However, given adequate amount of time and opportunity to work further with 
the isolated cells, testing for the expression of the adipocyte genes examined in this 
project (aP2 and c/EBPα) was a feasible next step.   Because both genes were expressed 
in the differentiated MSC cell lines 10T½ and OP9, it would be expected that the FACS 
sorted cells would also express aP2 and c/EBPα.   Compared to adipocytes, it is expected 
that MSC express less aP2 and c/EBPα. 
In the future, other genes also known to be associated with differentiated MSCs 
should also be examined, such as Prmt5, which has been suggested to be necessary for 
differentiation-dependent gene expression changes in mesenchymal precursor cells 
(LeBlanc et al., 2012).   
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